Sorry, you need to enable JavaScript to visit this website.
Skip directly to content

QUESTIONS TO ASK ABOUT AF AND AF-RELATED STROKE

 
QUESTIONS TO ASK ABOUT AF AND AF-RELATED STROKE
 
 

If you or someone close to you has been diagnosed with AF you may have questions for your doctor, nurse, or another healthcare professional about the type of medication that you or your loved one has been prescribed.

Current guidelines recommend that the majority of people at risk of AF-related stroke should be prescribed one of the following medicines, which are known as anticoagulants:1,2

  • Apixaban
  • Dabigatran
  • Edoxaban
  • Rivaroxaban
  • Warfarin

Not all of these medicines are appropriate for all patients or all types of AF, so you should discuss with your doctor which of them may be right for you.

TOP QUESTIONS TO ASK ABOUT PREVENTING AF-RELATED STROKE AND ANTICOAGULATION THERAPY

  1. Does my diagnosis of AF mean that I am at risk of AF-related stroke and how high is my risk?
  2. Do I need medication to reduce my risk of an AF-related stroke?
  3. What are the medication options to reduce my risk of an AF-related stroke and what are the differences between them?
  4. Are there any restrictions on my lifestyle as a result of the medication I have been/or may be prescribed?
  5. (If you are an AF patient and taking aspirin) Have I been prescribed aspirin to reduce my risk of AF-related stroke, if so have I also been prescribed an anticoagulant?
  6. Should I continue to take aspirin if I am also prescribed an anticoagulant?
References: 
  1. National Institute for Health and Care Excellence (NICE). Atrial Fibrillation: management. Clinical Guideline (CG180). June 2014. Available at: https://www.nice.org.uk/guidance/CG180. Last accessed: May 2018
  2. National Institute for Health and Care Excellence (NICE). Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. Technology Appraisal Guidance. September 2015. Available at:
    https://www.nice.org.uk/guidance/ta355/resources/edoxaban-for-preventing-stroke-and-systemic-embolism-in-people-with-nonvalvular-atrial-fibrillation-82602669987781. Last accessed: May 2018